Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint about Trixeo promotional claims (spacer use, lung deposition %, and missing Symbicort PI). PMCPA Panel found no breach of the 2021…
A US Kerendia (finerenone) DTC banner campaign was inadvertently accessible on MailOnline in the UK. The Panel found it was promotional POM…
Grünenthal voluntarily admitted it could not locate/retain ~30 certified hard-copy items and signatures. The PMCPA ruled breaches of Clauses 5.1 and 8.6…
A P3 Pharmacy interview featuring Teva content was ruled promotional. The article lacked PI, AE reporting statement, certification and Ajovy’s black triangle,…
Ferring confirmed withdrawal of Pentasa material with incorrect dosing info, but a hidden website hyperlink kept the leavepiece accessible for ~11 weeks.…
Dr Falk was ruled in breach of Clause 5.1 after a Budenofalk digital ad remained in use 12 weeks after agreeing to…
A naloxone awareness poster on a telephone booth linked to a website showing branded naloxone products. PMCPA ruled it advertised a POM…
A Google search found a booking form for a third‑party weight management webinar previously ruled in breach. Panel said Novo Nordisk hadn’t…
A third-party promotional webpage had a non-functioning single-click PI link for Pradaxa/Praxbind for ~3 weeks. An earlier email alert to medical information…
A supplier payment-terms letter sent to 266 UK vendors included promotional language about three medicines and an asset in development. It was…
Complaint alleged a Daily Mail article promoted Shingrix (POM) to the public. PMCPA found no evidence the article resulted from GSK’s business…
PMCPA found sales aids, leavepieces and rep briefing docs implied Nilemdo/Nustendi could be added to any statin dose. Simvastatin >40mg contraindication wasn’t…
GSK’s HCP website described Trelegy Ellipta as “A simple choice. One inhaler, easy to use and quick to teach”. A health professional…
Pulse ad for Trixeo linked COPD exacerbations and death with a “Take action with Trixeo” call-to-action, creating an unsubstantiated and misleading implication…
Complaint about symposium slides allegedly lacking job codes and a speaker’s ‘mismatch of the vaccine’ comment. PMCPA ruled no breach of Clauses…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
